Cutera, Inc.  

(Public, NASDAQ:CUTR)   Watch this stock  
Find more results for CUTR
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 8.80 - 15.69
Open     -
Vol / Avg. 0.00/64,558.00
Mkt cap 207.95M
P/E     -
Div/yield     -
EPS -0.74
Shares 14.57M
Beta 1.00
Inst. own 69%
Aug 3, 2015
Q2 2015 Cutera Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 18, 2015
Cutera Inc Annual Shareholders Meeting (Estimated) - 10:00AM EDT - Add to calendar
May 7, 2015
Q1 2015 Cutera Inc Earnings Call - Webcast
May 7, 2015
Q1 2015 Cutera Inc Earnings Release
Mar 11, 2015
Cutera Inc at ROTH Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -19.11% -13.58%
Operating margin -18.89% -13.59%
EBITD margin - -11.88%
Return on average assets -13.73% -9.75%
Return on average equity -18.38% -12.88%
Employees 266 -
CDP Score - -


3240 Bayshore Boulevard
United States - Map
+1-415-6575500 (Phone)
+1-415-3302444 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Cutera, Inc. is a global medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and light-based aesthetics systems for practitioners worldwide. The Company offers products based on four primary platforms/systems Xeo, GenesisPlusTM, ExcelVTM, and truSculptTM each of which enables physicians and other qualified practitioners to perform safe aesthetic procedures for their customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. Other than the above mentioned four primary systems, the Company generates revenue from its products such as CoolGlide, Solera, VariliteTM, and a third-party sourced system called myQTM for the Japanese market.

Officers and directors

Kevin P. Connors President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ronald J. Santilli Chief Financial Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David B. Apfelberg M.D. Lead Independent Director
Age: 73
Bio & Compensation  - Reuters
Gregory Barrett Independent Director
Age: 61
Bio & Compensation  - Reuters
Timothy J. O'Shea Independent Director
Age: 62
Bio & Compensation  - Reuters
J. Daniel Plants Independent Director
Age: 47
Bio & Compensation  - Reuters
Clinton H. Severson Independent Director
Age: 66
Bio & Compensation  - Reuters